The pathophysiological states with insulin resistance, including obesity and type 2 diabetes, are associated with increased expression of inducible nitric oxide synthase (iNOS) and oxidative stress. The diverse actions of nitric oxide (NO) can be classified in two categories; the direct effects of NO (e.g., cGMP-dependent vasodilation), and the indirect, redox state-dependent effects that are mediated by reactive nitrogen species (e.g., NO+, OONO-) through nitrosative protein modifications such as S-nitrosylation and tyrosine nitration. Nitrosative posttranslational modifications modulate functions of the variety of proteins, and are associated with iNOS induction. iNOS induction and resultant nitrosative protein modifications have been implicated in the development of many disorders, including hypertension, atherosclerosis, neurodegenerative disease, as well as type 1 diabetes and chronic diabetic complications. iNOS induction leads to prolonged, exaggerated production of NO and accelerates oxidative stress. Conversely, concomitant oxidative stress promotes nitrosative protein modifications. Our preliminary data both in vivo and in vitro indicate that (1) Akt/PKB, which plays a pivotal role in insulin action, is inactivated by NO+ (nitrosonium ion) donors both in intact cells and in vitro through nitrosative cysteine (thiol) modifications, (2) glycogen synthase kinase-3beta (GSK-3beta) activity is up- regulated by NO donor in a redox state-dependent manner, (3) iNOS-/- ob/ob mice are protected from developing hyperglycemia and exhibit relatively lower plasma insulin level compared with iNOS+/+ ob/ob mice, and (4) acute and chronic treatment of genetically obese, diabetic (ob/ob) mice with iNOS inhibitors, L- NIL and aminoguanidine results in decreases in blood glucose levels with concomitant glycogen synthase activation and glycogen phosphorylase inactivation. Based on these compelling and convincing preliminary data, we wish to test the hypothesis that iNOS plays a critical role in the pathogenesis of insulin resistance. The immediate goal of this proposal is, therefore, to confirm this hypothesis and clarify the molecular mechanisms by which iNOS induces insulin resistance. With this in mind, the following specific aims will be investigated.
Specific Aim 1 and 2 will determine the inhibitory and stimulatory effects of NO+ on Akt/PKB and GSK 3beta activity and the molecular mechanism for this process. The importance of nitrosative modification of cysteine residue(s) of Akt/PKB and GSK-3beta will be clarified by examining the effects of NO donor on these kinases with Cysteine to Serine substitutions. The biological relevance of RNS-mediated inactivation of Akt/PKB and activation of GSK-3beta will be confirmed with tissue samples from iNOS-/- ob/ob and iNOS+/+ ob/ob mice.
Specific Aim 3 will determine whether iNOS is required for insulin resistance related to obesity in vivo . This hypothesis will be tested by examining the effects of iNOS deficiency in ob/ob background. We have mated iNOS-/-and ob/ob mice and generated both iNOS-/- ob/ob and NOS+/+ ob/ob mice. Insulin sensitivity will be evaluated by insulin tolerance test. The long-term objectives of this proposal are, therefore, to develop novel interventions for treatment of insulin resistance and type 2 diabetes. In the short-term, the proposed studies will provide novel significant insights into the pathogenesis of insulin resistance, and also a scientific basis for development of novel therapeutic strategies to prevent and/or treat insulin resistance, and type 2 diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK058127-01A1
Application #
6433876
Study Section
Metabolism Study Section (MET)
Program Officer
Blondel, Olivier
Project Start
2002-07-01
Project End
2005-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
1
Fiscal Year
2002
Total Cost
$312,748
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Tanaka, Tomokazu; Ikegami, Yuichi; Nakazawa, Harumasa et al. (2017) Low-Dose Farnesyltransferase Inhibitor Suppresses HIF-1? and Snail Expression in Triple-Negative Breast Cancer MDA-MB-231 Cells In Vitro. J Cell Physiol 232:192-201
Shinozaki, Shohei; Chang, Kyungho; Sakai, Michihiro et al. (2014) Inflammatory stimuli induce inhibitory S-nitrosylation of the deacetylase SIRT1 to increase acetylation and activation of p53 and p65. Sci Signal 7:ra106
Kaneki, Masao; Fukushima, Yuji; Shinozaki, Shohei et al. (2013) iNOS inhibitor, L-NIL, reverses burn-induced glycogen synthase kinase-3? activation in skeletal muscle of rats. Metabolism 62:341-6
Coppadoro, Andrea; Berra, Lorenzo; Kumar, Asheesh et al. (2013) Critical illness is associated with decreased plasma levels of coenzyme Q10: a cross-sectional study. J Crit Care 28:571-6
Fukaya, Makiko; Tamura, Yoshiaki; Chiba, Yuko et al. (2013) Protective effects of a nicotinamide derivative, isonicotinamide, against streptozotocin-induced ?-cell damage and diabetes in mice. Biochem Biophys Res Commun 442:92-8
Sugita, Michiko; Sugita, Hiroki; Kim, Minhye et al. (2012) Inducible nitric oxide synthase deficiency ameliorates skeletal muscle insulin resistance but does not alter unexpected lower blood glucose levels after burn injury in C57BL/6 mice. Metabolism 61:127-36
Tamura, Yoshiaki; Watanabe, Keiichi; Kantani, Tomomi et al. (2011) Upregulation of circulating IL-15 by treadmill running in healthy individuals: is IL-15 an endocrine mediator of the beneficial effects of endurance exercise? Endocr J 58:211-5
Tamura, Yoshiaki; Chiba, Yuko; Tanioka, Toshihiro et al. (2011) NO donor induces Nec-1-inhibitable, but RIP1-independent, necrotic cell death in pancreatic ýý-cells. FEBS Lett 585:3058-64
Kida, Kotaro; Yamada, Marina; Tokuda, Kentaro et al. (2011) Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson's disease. Antioxid Redox Signal 15:343-52
Yamada, Marina; Kida, Kotaro; Amutuhaire, Willington et al. (2010) Gene disruption of caspase-3 prevents MPTP-induced Parkinson's disease in mice. Biochem Biophys Res Commun 402:312-8

Showing the most recent 10 out of 25 publications